Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Ibuprofen |
Active Ingredient: | Ibuprofen 200mg |
Dosage Form: | Liquid filled capsule |
New Zealand Sponsor: | Multichem NZ Limited |
Manufacturer: | Geltec Private Limited, Bangalore, India |
Product: | Panadol Liquid Caps (General sale) |
Active Ingredient: | Paracetamol 500mg |
Dosage Form: | Liquid filled capsule |
New Zealand Sponsor: | AA-Med NZ Limited |
Manufacturer: | Olive Healthcare, Daman, India |
Product: | Panadol Liquid Caps (Pharmacy only) |
Active Ingredient: | Paracetamol 500mg |
Dosage Form: | Liquid filled capsule |
New Zealand Sponsor: | AA-Med NZ Limited |
Manufacturer: | Olive Healthcare, Daman, India |
Product: | Zejula |
Active Ingredient: | Niraparib tosilate monohydrate 159.3mg equivalent to niraparib 100mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | GlaxoSmithKline NZ Limited |
Manufacturers: | Catalent Greenville Inc, North Carolina, United States of America WuXi STA Pharmaceutical Co. Limited, Wuxi, China |
Dated this 21st day of June 2024.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).